{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:09:38Z","timestamp":1778800178995,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Korea Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2024-00335936"],"award-info":[{"award-number":["RS-2024-00335936"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Korea Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2024-00439277"],"award-info":[{"award-number":["RS-2024-00439277"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003081","name":"Ministry of Education, Ethiopia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003569","name":"Korea Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["25212MFDS002"],"award-info":[{"award-number":["25212MFDS002"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2120240615426"],"award-info":[{"award-number":["2120240615426"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.anai.2025.12.002","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T16:23:50Z","timestamp":1764951830000},"page":"538-544.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clustering of patients with severe asthma based on long-term percentage of forced expiratory volume in 1 second (FEV1) changes"],"prefix":"10.1016","volume":"136","author":[{"given":"Youngsoo","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9622-0232","authenticated-orcid":false,"given":"Junhyuk","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chungsoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunyoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Hyuk","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rae Woong","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2614-0303","authenticated-orcid":false,"given":"Hae-Sim","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.anai.2025.12.002_bib0001","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1034\/j.1398-9995.2001.00143.x","article-title":"Severe asthma: definition and mechanisms","volume":"56","author":"Stirling","year":"2001","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.anai.2025.12.002_bib0002","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00588-2019","article-title":"Management of severe asthma: a European Respiratory Society\/American Thoracic Society guideline","volume":"55","author":"Holguin","year":"2020","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.anai.2025.12.002_bib0003","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jaci.2014.08.042","article-title":"The prevalence of severe refractory asthma","volume":"135","author":"Hekking","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.12.002_bib0004","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4168\/aair.2024.16.5.462","article-title":"Update on inflammatory biomarkers for defining asthma phenotype","volume":"16","author":"Sim","year":"2024","journal-title":"Allergy Asthma Immunol Res"},{"issue":"6","key":"10.1016\/j.anai.2025.12.002_bib0005","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1067\/mai.2000.111307","article-title":"Pathophysiology of severe asthma","volume":"106","author":"Busse","year":"2000","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.12.002_bib0006","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/resp.13251","article-title":"Pathophysiology of severe asthma: we\u2019ve only just started","volume":"23","author":"King","year":"2018","journal-title":"Respirology"},{"issue":"3","key":"10.1016\/j.anai.2025.12.002_bib0007","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4168\/aair.2024.16.3.253","article-title":"Real-world effectiveness of biologics in patients with severe asthma: analysis of the KoSAR","volume":"16","author":"Park","year":"2024","journal-title":"Allergy Asthma Immunol Res"},{"issue":"1","key":"10.1016\/j.anai.2025.12.002_bib0008","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4168\/aair.2017.9.1.3","article-title":"Development of new therapies for severe asthma","volume":"9","author":"Fajt","year":"2017","journal-title":"Allergy Asthma Immunol Res"},{"issue":"2","key":"10.1016\/j.anai.2025.12.002_bib0009","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/resp.13730","article-title":"Rational oral corticosteroid use in adult severe asthma: a narrative review","volume":"25","author":"Chung","year":"2020","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.anai.2025.12.002_bib0010","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1080\/02770903.2019.1705335","article-title":"Severe asthma: oral corticosteroid alternatives and the need for optimal referral pathways","volume":"58","author":"Cataldo","year":"2021","journal-title":"J Asthma"},{"issue":"4","key":"10.1016\/j.anai.2025.12.002_bib0011","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1164\/rccm.200906-0896OC","article-title":"Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program","volume":"181","author":"Moore","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.anai.2025.12.002_bib0012","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1016\/j.jaip.2021.02.059","article-title":"Cluster analysis of inflammatory biomarker expression in the international severe asthma registry","volume":"9","author":"Denton","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2025.12.002_bib0013","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jaci.2013.10.011","article-title":"Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis","volume":"133","author":"Moore","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.12.002_bib0014","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/all.13966","article-title":"Different endotypes and phenotypes drive the heterogeneity in severe asthma","volume":"75","author":"McDowell","year":"2020","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.anai.2025.12.002_bib0015","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2500\/aap.2015.36.3908","article-title":"Severe asthma: epidemiology, burden of illness, and heterogeneity","volume":"36","author":"Lang","year":"2015","journal-title":"Allergy Asthma Proc"},{"issue":"1","key":"10.1016\/j.anai.2025.12.002_bib0016","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S2213-2600(13)70288-1","article-title":"Asthma heterogeneity and severity\u2014why is comprehensive phenotyping important?","volume":"2","author":"Moore","year":"2013","journal-title":"Lancet Respir Med"},{"issue":"27","key":"10.1016\/j.anai.2025.12.002_bib0017","doi-asserted-by":"crossref","first-page":"7329","DOI":"10.1073\/pnas.1510502113","article-title":"Characterizing treatment pathways at scale using the OHDSI network","volume":"113","author":"Hripcsak","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.anai.2025.12.002_bib0018","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jaci.2021.06.015","article-title":"Trajectories of adiposity indicators and association with asthma and lung function in urban minority children","volume":"148","author":"Lovinsky-Desir","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.12.002_bib0019","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1164\/rccm.201801-0190OC","article-title":"Longitudinal phenotypes of respiratory health in a high-risk urban birth cohort","volume":"199","author":"Bacharier","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.anai.2025.12.002_bib0020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/0095798420930932","article-title":"Latent class analysis: a guide to best practice","volume":"46","author":"Weller","year":"2020","journal-title":"J Black Psychol"},{"issue":"4","key":"10.1016\/j.anai.2025.12.002_bib0021","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jaip.2016.04.022","article-title":"The minimally clinically important difference (MCID): what difference does it make?","volume":"4","author":"Bernstein","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2025.12.002_bib0022","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaip.2017.05.015","article-title":"Severe asthma phenotypes\u2014how should they guide evaluation and treatment?","volume":"5","author":"Fitzpatrick","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"suppl","key":"10.1016\/j.anai.2025.12.002_bib0023","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1513\/AnnalsATS.201309-307AW","article-title":"Clinical heterogeneity in the severe asthma research program","volume":"10","author":"Moore","year":"2013","journal-title":"Ann Am Thorac Soc"},{"issue":"10","key":"10.1016\/j.anai.2025.12.002_bib0024","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1016\/j.jaip.2023.05.034","article-title":"Cluster analysis of Finnish population-based adult-onset asthma patients","volume":"11","author":"Ilmarinen","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2025.12.002_bib0025","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.chest.2019.10.053","article-title":"Characterization of severe asthma worldwide: data from the International Severe Asthma Registry","volume":"157","author":"Wang","year":"2020","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.anai.2025.12.002_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2024.100903","article-title":"Work-related asthma in adults with severe asthma from the Korean Severe Asthma Registry (KoSAR)","volume":"17","author":"Lee","year":"2024","journal-title":"World Allergy Organ J"},{"issue":"9","key":"10.1016\/j.anai.2025.12.002_bib0027","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1365-2222.2005.02328.x","article-title":"Environmental risk factors and allergic bronchial asthma","volume":"35","author":"D\u2019Amato","year":"2005","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.anai.2025.12.002_bib0028","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s12016-020-08830-5","article-title":"External environmental pollution as a risk factor for asthma","volume":"62","author":"Chatkin","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.12.002_bib0029","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1164\/rccm.201301-0156OC","article-title":"Ten-year follow-up of cluster-based asthma phenotypes in adults: a pooled analysis of three cohorts","volume":"188","author":"Boudier","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.anai.2025.12.002_bib0030","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.anai.2018.07.033","article-title":"Selecting the right biologic for your patients with severe asthma","volume":"121","author":"Manka","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9842","key":"10.1016\/j.anai.2025.12.002_bib0031","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","article-title":"Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial","volume":"380","author":"Pavord","year":"2012","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.anai.2025.12.002_bib0032","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1164\/rccm.201103-0396OC","article-title":"Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study","volume":"184","author":"Castro","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.anai.2025.12.002_bib0033","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S2213-2600(15)00042-9","article-title":"Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"3","author":"Castro","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"9","key":"10.1016\/j.anai.2025.12.002_bib0034","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-154-9-201105030-00002","article-title":"Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial","volume":"154","author":"Hanania","year":"2011","journal-title":"Ann Intern Med"},{"issue":"26","key":"10.1016\/j.anai.2025.12.002_bib0035","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N Engl J Med"},{"issue":"10056","key":"10.1016\/j.anai.2025.12.002_bib0036","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of Benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting \u03b22-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.anai.2025.12.002_bib0037","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.3390\/biomedicines9111684","article-title":"Characterization of T2-low and T2-high asthma phenotypes in real life","volume":"9","author":"Ricciardolo","year":"2021","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.anai.2025.12.002_bib0038","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3390\/biom13071118","article-title":"Type 2 low biomarker stability and exacerbations in severe uncontrolled asthma","volume":"13","author":"Viinanen","year":"2023","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.anai.2025.12.002_bib0039","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jaci.2014.04.005","article-title":"Lung function decline and variable airway inflammatory pattern: longitudinal analysis of severe asthma","volume":"134","author":"Newby","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.anai.2025.12.002_bib0040","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/thorax-2021-217032","article-title":"Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study","volume":"78","author":"Soremekun","year":"2023","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.anai.2025.12.002_bib0041","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1378\/chest.07-1881","article-title":"Differences in airway cytokine profile in severe asthma compared to moderate asthma","volume":"133","author":"Shannon","year":"2008","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.anai.2025.12.002_bib0042","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S2213-2600(21)00004-7","article-title":"The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study","volume":"9","author":"McDowell","year":"2021","journal-title":"Lancet Respir Med"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120625013717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120625013717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:32:24Z","timestamp":1778797944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120625013717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1081120625013717"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2025.12.002","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clustering of patients with severe asthma based on long-term percentage of forced expiratory volume in 1 second (FEV1) changes","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2025.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}